Castellino SM, Li H, Herrera AF, LeBlanc M, et al. Three-Year Follow-Up of Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Adolescents With Advanced-Stage Classic Hodgkin Lymphoma on S1826. J Clin Oncol 2026 Jan 9:JCO2500203. doi: 10.1200/JCO-25-00203.
PMID: 41512237